Purchase Order 75D30121P11422
Award Date 6/28/21
Potential Completion Date 8/15/21
Potential Value $42K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Castleton, IN 46256, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This $90,000.00 firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for MAGNA PURE 96 products. The contract has no set-aside designation and has a completion date of July 23, 2022. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. They have previously received prime contract and subcontract awards from various federal...
- This is a $97,000.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The contract, titled "MAGNA 96", has an ultimate completion date of November 30, 2015 and does not have a set-aside designation. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment,...
- The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $90,000 firm fixed price purchase order to Roche Diagnostics Corporation. Under this contract, Roche will deliver MAGNA PURE 96 INSTRUMENTS to the CDC location in Castleton, Indiana by September 20, 2023 to support the agency's disease prevention and health promotion efforts. As one of the largest government contractors in the medical device sector, Roche will leverage existing...
- Roche Diagnostics Corporation was awarded a firm fixed price purchase order by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh. The award, valued at two hundred thirty-seven thousand seven hundred forty-one dollars and sixty cents ($237,741.60), is for the product "MAGNA PURE 96" and has a completion date of October 15, 2020. The place of performance is Castleton, Indiana. No set-aside designation was used for this contract. Roche...
- The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded Roche Diagnostics Corporation a $53,105 purchase order contract to provide MAGNA PURE24 products. The contract has a firm fixed price and period of performance from September 19, 2023 through October 31, 2023. Place of performance will be Roche's facility in Castleton, Indiana. No subcontractors or set aside designations were identified. The CDC likely requires the MAGNA PURE24...
- This is a $97,000.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the acquisition of MAGNA PURE EQUIPMENT and does not have a set-aside designation. Roche Diagnostics has received multiple prime contract and subcontract awards from various federal agencies to provide...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for MAGNA PURE KIT. The potential value of the contract is $118,665.00 and the completion date is March 31, 2022. Roche Diagnostics is a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract does...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the delivery of MAGNA PURE 96 INSTRUMENTS. The contract, which has a potential value of $180,000.00, does not have a set-aside designation and has an anticipated completion date of April 15, 2022. Roche Diagnostics, a foreign-owned, for-profit manufacturer of in vitro diagnostics,...
- This is a $84,382.00 firm fixed price purchase order awarded by the Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the provision of Roche Magna Pure Kits/Zika and does not have a set-aside designation. Roche Diagnostics has been awarded numerous federal contracts and...
- This is a $144,721.10 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for laboratory supplies. The contract has no set-aside designation. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. Roche has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and...